LINC00982 | long intergenic non-protein coding RNA 982 | 1p36.32 | 0.624 | 0.787 | 0
|
OLFM1 | olfactomedin 1 | 9q34.3 | 0.356 | 0.552 | 0
|
A2M | alpha-2-macroglobulin | 12p13.31 | 0.355 | 0.421 | 0
|
RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 11q13 | 0.349 | 0.474 | 0
|
FBLN5 | fibulin 5 | 14q31 | 0.345 | 0.468 | 0
|
ELN | elastin | 7q11.1-q21.1 | 0.34 | 0.427 | 0
|
LIMS2 | LIM and senescent cell antigen-like domains 2 | 2q21.1 | 0.34 | 0.469 | 0
|
ADAMTS10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 | 19p13.2 | 0.338 | 0.458 | 0
|
ADRA2A | adrenoceptor alpha 2A | 10q25.2 | 0.337 | 0.491 | 0
|
NCAM1 | neural cell adhesion molecule 1 | 11q23.2 | 0.337 | 0.413 | 0
|
EBF1 | early B-cell factor 1 | 5q34 | 0.337 | 0.436 | 0
|
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 1q23.2 | 0.333 | 0.409 | 0
|
PYGM | phosphorylase, glycogen, muscle | 11q12-q13.2 | 0.333 | 0.489 | 0
|
FHL1 | four and a half LIM domains 1 | Xq26.3 | 0.331 | 0.414 | 0
|
JAM2 | junctional adhesion molecule 2 | 21q21.2 | 0.33 | 0.473 | 0
|
JAM3 | junctional adhesion molecule 3 | 11q25 | 0.328 | 0.479 | 0
|
HSPB6 | heat shock protein, alpha-crystallin-related, B6 | 19q13.13 | 0.327 | 0.424 | 0
|
C4A | complement component 4A (Rodgers blood group) | 6p21.3 | 0.327 | 0.407 | 0
|
NEGR1 | neuronal growth regulator 1 | 1p31.1 | 0.324 | 0.431 | 0
|
BOC | BOC cell adhesion associated, oncogene regulated | 3q13.2 | 0.324 | 0.448 | 0
|
AQP1 | aquaporin 1 (Colton blood group) | 7p14 | 0.323 | 0.399 | 0
|
GNG7 | guanine nucleotide binding protein (G protein), gamma 7 | 19p13.3 | 0.323 | 0.493 | 0
|
SNED1 | sushi, nidogen and EGF-like domains 1 | 2q37.3 | 0.323 | 0.49 | 0
|
SRL | sarcalumenin | 16p13.3 | 0.322 | 0.43 | 0
|
CCL14 | chemokine (C-C motif) ligand 14 | 17q12 | 0.321 | 0.42 | 0
|
SPARCL1 | SPARC-like 1 (hevin) | 4q22-q25 | 0.321 | 0.417 | 0
|
P2RX1 | purinergic receptor P2X, ligand gated ion channel, 1 | 17p13.3 | 0.32 | 0.431 | 0
|
PTGDS | prostaglandin D2 synthase 21kDa (brain) | 9q34.2-q34.3 | 0.318 | 0.468 | 0
|
CSDC2 | cold shock domain containing C2, RNA binding | 22q13.2 | 0.317 | 0.42 | 0
|
LCN10 | lipocalin 10 | 9q34.3 | 0.317 | 0.46 | 0
|
KIAA1644 | KIAA1644 | 22q13 | 0.316 | 0.39 | 0
|
TNXB | tenascin XB | 6p21.3 | 0.316 | 0.5 | 0
|
MIR100HG | mir-100-let-7a-2 cluster host gene | 11q24.1 | 0.315 | 0.425 | 0
|
CADM3 | cell adhesion molecule 3 | 1q21.2-q22 | 0.315 | 0.441 | 0
|
DACT3 | dishevelled-binding antagonist of beta-catenin 3 | 19q13.32 | 0.314 | 0.437 | 0
|
CD79B | CD79b molecule, immunoglobulin-associated beta | 17q23 | 0.314 | 0.427 | 0
|
DHH | desert hedgehog | 12q13.1 | 0.314 | 0.41 | 0
|
CTSG | cathepsin G | 14q12 | 0.313 | 0.393 | 0
|
ADGRD1 | adhesion G protein-coupled receptor D1 | 12q24.33 | 0.312 | 0.474 | 0
|
ITGA7 | integrin, alpha 7 | 12q13 | 0.312 | 0.446 | 0
|
NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 15q24-q25 | 0.31 | 0.466 | 0
|
ACKR1 | atypical chemokine receptor 1 (Duffy blood group) | 1q21-q22 | 0.309 | 0.4 | 0
|
CLIP3 | CAP-GLY domain containing linker protein 3 | 19q13.12 | 0.308 | 0.471 | 0
|
VSTM4 | V-set and transmembrane domain containing 4 | 10q11.23 | 0.307 | 0.411 | 0
|
DCN | decorin | 12q21.33 | 0.307 | 0.401 | 0
|
HSPA12A | heat shock 70kDa protein 12A | 10q25.3 | 0.306 | 0.39 | 0
|
ABI3BP | ABI family, member 3 (NESH) binding protein | 3q12.2 | 0.306 | 0.44 | 0
|
RSPO1 | R-spondin 1 | 1p34.2 | 0.306 | 0.467 | 0
|
LMCD1 | LIM and cysteine-rich domains 1 | 3p26-p24 | 0.306 | 0.422 | 0
|
SH3RF3 | SH3 domain containing ring finger 3 | 2q13 | 0.303 | 0.451 | 0
|
MRGPRF | MAS-related GPR, member F | 11q13.1 | 0.3 | 0.463 | 0
|
NRXN1 | neurexin 1 | 2p16.3 | 0.3 | 0.364 | 9.94e-15
|
FXYD1 | FXYD domain containing ion transport regulator 1 | 19q13.1 | 0.3 | 0.414 | 0
|
SOD3 | superoxide dismutase 3, extracellular | 4p15.2 | 0.299 | 0.457 | 0
|
PI16 | peptidase inhibitor 16 | 6p21.31 | 0.297 | 0.424 | 0
|
PDZRN3 | PDZ domain containing ring finger 3 | 3p14.1 | 0.296 | 0.489 | 0
|
C7 | complement component 7 | 5p13.1 | 0.296 | 0.455 | 0
|
P4HA3 | prolyl 4-hydroxylase, alpha polypeptide III | 11q13.4 | 0.294 | 0.359 | 2.69e-14
|
CXCR5 | chemokine (C-X-C motif) receptor 5 | 11q23.3 | 0.293 | 0.371 | 2.46e-15
|
HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) | 1p36.13 | 0.292 | 0.424 | 0
|
ITGA9 | integrin, alpha 9 | 3p21.3 | 0.291 | 0.45 | 0
|
EBF3 | early B-cell factor 3 | 10q26.3 | 0.289 | 0.406 | 0
|
CCL19 | chemokine (C-C motif) ligand 19 | 9p13 | 0.289 | 0.41 | 0
|
INMT | indolethylamine N-methyltransferase | 7p14.3 | 0.287 | 0.397 | 0
|
SORCS1 | sortilin-related VPS10 domain containing receptor 1 | 10q23-q25 | 0.286 | 0.4 | 0
|
MS4A2 | membrane-spanning 4-domains, subfamily A, member 2 | 11q12-q13 | 0.284 | 0.394 | 0
|
PDZD4 | PDZ domain containing 4 | Xq28 | 0.284 | 0.478 | 0
|
BLK | BLK proto-oncogene, Src family tyrosine kinase | 8p23-p22 | 0.283 | 0.395 | 0
|
NAPSB | napsin B aspartic peptidase, pseudogene | 19q13.33 | 0.282 | 0.323 | 9.83e-12
|
GNAZ | guanine nucleotide binding protein (G protein), alpha z polypeptide | 22q11.1-q11.2 | 0.275 | 0.481 | 0
|
POU6F1 | POU class 6 homeobox 1 | 12q13.13 | 0.274 | 0.458 | 0
|
TNFAIP8L3 | tumor necrosis factor, alpha-induced protein 8-like 3 | 15q21.2 | 0.273 | 0.312 | 5.14e-11
|
MSRB3 | methionine sulfoxide reductase B3 | 12q14.3 | 0.271 | 0.399 | 0
|
DIO3 | deiodinase, iodothyronine, type III | 14q32 | 0.27 | 0.421 | 0
|
FCRL1 | Fc receptor-like 1 | 1q21-q22 | 0.27 | 0.314 | 4.08e-11
|
LAX1 | lymphocyte transmembrane adaptor 1 | 1q32.1 | 0.268 | 0.353 | 8.11e-14
|
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | 17q25.3 | 0.265 | 0.39 | 0
|
ADPRH | ADP-ribosylarginine hydrolase | 3q13.31-q13.33 | 0.265 | 0.362 | 1.48e-14
|
TLR10 | toll-like receptor 10 | 4p14 | 0.264 | 0.289 | 1.43e-09
|
RERGL | RERG/RAS-like | 12p12.3 | 0.264 | 0.377 | 6.01e-16
|
SARDH | sarcosine dehydrogenase | 9q33-q34 | 0.264 | 0.353 | 7.01e-14
|
CNR2 | cannabinoid receptor 2 (macrophage) | 1p | 0.263 | 0.34 | 7.12e-13
|
CD19 | CD19 molecule | 16p11.2 | 0.261 | 0.331 | 3.01e-12
|
VIPR2 | vasoactive intestinal peptide receptor 2 | 7q36.3 | 0.259 | 0.447 | 0
|
CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 16q24 | 0.257 | 0.351 | 1.07e-13
|
KIAA0125 | KIAA0125 | 14q32.33 | 0.252 | 0.354 | 6.01e-14
|
REEP1 | receptor accessory protein 1 | 2p11.2 | 0.251 | 0.468 | 0
|
RADIL | Ras association and DIL domains | 7p22.1 | 0.25 | 0.445 | 0
|
PHKG1 | phosphorylase kinase, gamma 1 (muscle) | 7p11.2 | 0.246 | 0.316 | 3.1e-11
|
KALRN | kalirin, RhoGEF kinase | 3q21.2 | 0.246 | 0.386 | 0
|
CRLF1 | cytokine receptor-like factor 1 | 19p12 | 0.241 | 0.311 | 6.71e-11
|
QPRT | quinolinate phosphoribosyltransferase | 16p11.2 | 0.241 | 0.272 | 1.25e-08
|
CLEC17A | C-type lectin domain family 17, member A | 19p13.12 | 0.24 | 0.32 | 1.69e-11
|
MYH3 | myosin, heavy chain 3, skeletal muscle, embryonic | 17p13.1 | 0.24 | 0.328 | 4.9e-12
|
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | 17q24 | 0.24 | 0.313 | 4.38e-11
|
LINC00908 | long intergenic non-protein coding RNA 908 | 18q23 | 0.235 | 0.301 | 2.64e-10
|
TRIM58 | tripartite motif containing 58 | 1q44 | 0.235 | 0.3 | 3.19e-10
|
PDE9A | phosphodiesterase 9A | 21q22.3 | 0.232 | 0.297 | 4.57e-10
|
ADRA2C | adrenoceptor alpha 2C | 4p16.3 | 0.231 | 0.291 | 1.09e-09
|
C2CD4B | C2 calcium-dependent domain containing 4B | 15q22.2 | 0.23 | 0.383 | 9.38e-17
|
JADE1 | jade family PHD finger 1 | 4q26-q27 | 0.229 | 0.345 | 3.13e-13
|
C9orf47 | chromosome 9 open reading frame 47 | 9q22.1 | 0.228 | 0.343 | 4.31e-13
|
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | 16p13.3 | 0.228 | 0.392 | 0
|
RAN | RAN, member RAS oncogene family | 12q24.33 | 0.227 | -0.341 | 5.76e-13
|
IGSF22 | immunoglobulin superfamily, member 22 | 11p15.1 | 0.226 | -0.007 | 0.879
|
MTAP | methylthioadenosine phosphorylase | 9p21 | 0.225 | 0.098 | 0.0425
|
IL17D | interleukin 17D | 13q11 | 0.224 | 0.404 | 0
|
PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 11q13-q14 | 0.224 | -0.225 | 2.74e-06
|
ZNF853 | zinc finger protein 853 | 7p22.1 | 0.222 | 0.262 | 4.6e-08
|
SMNDC1 | survival motor neuron domain containing 1 | 10q23 | 0.221 | -0.297 | 4.66e-10
|
CHST8 | carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 | 19q13.1 | 0.219 | 0.286 | 2.13e-09
|
HPD | 4-hydroxyphenylpyruvate dioxygenase | 12q24.31 | 0.219 | 0.279 | 5.52e-09
|
RSPH3 | radial spoke 3 homolog (Chlamydomonas) | 6q25.3 | 0.218 | -0.297 | 4.64e-10
|
CLCA2 | chloride channel accessory 2 | 1p22.3 | 0.218 | -0.318 | 2.21e-11
|
SP5 | Sp5 transcription factor | 2q31 | 0.217 | 0.347 | 2.33e-13
|
ADSSL1 | adenylosuccinate synthase like 1 | 14q32.33 | 0.214 | -0.175 | 0.000287
|
MAN1C1 | mannosidase, alpha, class 1C, member 1 | 1p35 | 0.213 | 0.276 | 8.15e-09
|
EML2 | echinoderm microtubule associated protein like 2 | 19q13.32 | 0.21 | -0.192 | 6.52e-05
|
ZDHHC16 | zinc finger, DHHC-type containing 16 | 10q24.1 | 0.209 | -0.308 | 9.37e-11
|
TRIM6 | tripartite motif containing 6 | 11p15 | 0.206 | 0.229 | 1.92e-06
|
NEO1 | neogenin 1 | 15q22.3-q23 | 0.206 | 0.049 | 0.308
|
PLAG1 | pleiomorphic adenoma gene 1 | 8q12 | 0.204 | -0.33 | 3.51e-12
|
EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 1q42.1 | 0.204 | 0.229 | 1.82e-06
|
CDKN2B-AS1 | CDKN2B antisense RNA 1 | 9p21.3 | 0.203 | 0.126 | 0.00894
|
RNF157 | ring finger protein 157 | 17q25.3 | 0.203 | 0.248 | 2.39e-07
|
MMS19 | MMS19 homolog, cytosolic iron-sulfur assembly component | 10q24-q25 | 0.202 | -0.295 | 6.23e-10
|
SOCS2 | suppressor of cytokine signaling 2 | 12q | 0.199 | 0.282 | 3.6e-09
|
GAPVD1 | GTPase activating protein and VPS9 domains 1 | 9q34.11 | 0.199 | 0.015 | 0.75
|
SLC9A6 | solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 | Xq26.3 | 0.196 | -0.215 | 7.87e-06
|
APOBEC3D | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D | 22q13.1 | 0.195 | 0.106 | 0.0286
|
ASIC3 | acid sensing (proton gated) ion channel 3 | 7q35 | 0.195 | 0.219 | 5.11e-06
|
BLOC1S4 | biogenesis of lysosomal organelles complex-1, subunit 4, cappuccino | 4p16.1 | 0.193 | -0.271 | 1.42e-08
|
CLCA3P | chloride channel accessory 3, pseudogene | 1p22.3 | 0.191 | -0.298 | 4.03e-10
|
CDC42EP4 | CDC42 effector protein (Rho GTPase binding) 4 | 17q24-q25 | 0.191 | -0.134 | 0.00555
|
AVPI1 | arginine vasopressin-induced 1 | 10q24.2 | 0.191 | -0.201 | 2.86e-05
|
CLMN | calmin (calponin-like, transmembrane) | 14q32.13 | 0.19 | 0.151 | 0.00174
|
WISP3 | WNT1 inducible signaling pathway protein 3 | 6q21 | 0.188 | -0.3 | 3.24e-10
|
BRSK2 | BR serine/threonine kinase 2 | 11p15.5 | 0.186 | 0.374 | 1.14e-15
|
DNAH2 | dynein, axonemal, heavy chain 2 | 17p13.1 | 0.185 | -0.034 | 0.479
|
CBS | cystathionine-beta-synthase | 21q22.3 | 0.185 | 0.145 | 0.00263
|
TUBBP5 | tubulin, beta pseudogene 5 | 9q34.3 | 0.179 | 0.002 | 0.959
|
METTL9 | methyltransferase like 9 | 16p12.2 | 0.176 | -0.152 | 0.0017
|
PNPLA1 | patatin-like phospholipase domain containing 1 | 6p21.31 | 0.172 | -0.105 | 0.0306
|
CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 10q26.3 | 0.168 | 0.156 | 0.0012
|
PTGR2 | prostaglandin reductase 2 | 14q24.1-q24.2 | 0.167 | -0.091 | 0.0616
|
ASNS | asparagine synthetase (glutamine-hydrolyzing) | 7q21.3 | 0.161 | 0.005 | 0.918
|
DAGLA | diacylglycerol lipase, alpha | 11q12.3 | 0.156 | 0.125 | 0.00997
|